New Colon Cancer Concerns

Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients

View Today Show Segment with Dr. Marshall

The 2018 Ruesch Center Annual Report

Highlights of the Ruesch Center from the past year include our latest in research and clinical trials, partnerships regionally and internationally, and our education, advocacy and outreach efforts.

Check Out the Report

Patient & Families

Relentlessly fighting a smarter war against GI cancer by partnering with patients based on their unique needs, the Ruesch Center is committed to providing you with the highest standard of care and individualized cures.

Patients & Families

Current Clinical Trials

Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute

View Clinical Trials

Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.




Immunotherapy Could Have Role in Frontline HCC

January 23rd, 2019

In the search to establish new therapeutic options for patients with advanced hepatocellular carcinoma (HCC), immunotherapy has become a frontrunner in many clinical trials in the first-line setting, according to Michael J. Pishvaian, MD, PhD.

Looking for Zebras in Metastatic Colorectal Cancer

January 7th, 2019

Although colorectal cancer is one of the most commonly diagnosed cancers in the United States,1 and researchers’ understanding of the biology and pathophysiology of CRC has grown, its many variations require that each case be diagnosed with care.



Sign Up to receive all Ruesch updates directly in your Inbox

We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.